REMICADE: NICE Approves Two Biosimilars for Arthritis

Rheumatoid arthritis sufferers in England will soon be able to benefit from a cheaper generic version of US pharmaceutical producer Merck's and the world's bestselling medicines Remicade following a decision by the National Institute fo...